Synonyms: NRP104 | Vyvanse®
lisdexamfetamine is an approved drug (FDA (2007))
Compound class:
Synthetic organic
Comment: This drug is a prodrug of dexamphetamine. The amphetamine is released more slowly from this prodrug than by administering active amphetamine directly.
|
|
Classification ![]() |
|
Compound class | Synthetic organic |
Approved drug? | Yes (FDA (2007)) |
Approved drug? | Yes. FDA (2007) |
Is prodrug? | Yes |
Active form | dexamfetamine |
IUPAC Name ![]() |
(2S)-2,6-diamino-N-[(2S)-1-phenylpropan-2-yl]hexanimidic acid |
International Nonproprietary Names ![]() |
|
INN number | INN |
8690 | lisdexamfetamine |
Synonyms ![]() |
NRP104 | Vyvanse® |
Database Links ![]() |
|
CAS Registry No. | 608137-32-2 |
ChEMBL Ligand | CHEMBL1201222 |
DrugBank Ligand | DB01255 |
DrugCentral Ligand | 4135 |
GtoPdb PubChem SID | 178103788 |
PubChem CID | 11597698 |
Search Google for chemical match using the InChIKey | VOBHXZCDAVEXEY-JSGCOSHPSA-N |
Search Google for chemicals with the same backbone | VOBHXZCDAVEXEY |
Search PubMed clinical trials | lisdexamfetamine |
Search PubMed titles | lisdexamfetamine |
Search PubMed titles/abstracts | lisdexamfetamine |
UniChem Compound Search for chemical match using the InChIKey | VOBHXZCDAVEXEY-JSGCOSHPSA-N |
UniChem Connectivity Search for chemical match using the InChIKey | VOBHXZCDAVEXEY-JSGCOSHPSA-N |
Wikipedia | Lisdexamfetamine |